Chelsea Therapeutics International Company Profile (NASDAQ:CHTP)

About Chelsea Therapeutics International (NASDAQ:CHTP)

Chelsea Therapeutics International logoChelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CHTP
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -21.03
  • P/E Growth: 0
Dividend:
  • Dividend Yield: 1.0%
 

Frequently Asked Questions for Chelsea Therapeutics International (NASDAQ:CHTP)

What is Chelsea Therapeutics International's stock symbol?

Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."

Who are some of Chelsea Therapeutics International's key competitors?

How do I buy Chelsea Therapeutics International stock?

Shares of Chelsea Therapeutics International can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chelsea Therapeutics International's stock price today?

One share of Chelsea Therapeutics International stock can currently be purchased for approximately $6.52.


MarketBeat Community Rating for Chelsea Therapeutics International (NASDAQ CHTP)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  109
MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Chelsea Therapeutics International (NASDAQ:CHTP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Chelsea Therapeutics International (NASDAQ:CHTP)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Chelsea Therapeutics International (NASDAQ:CHTP)
Earnings by Quarter for Chelsea Therapeutics International (NASDAQ:CHTP)
Earnings History by Quarter for Chelsea Therapeutics International (NASDAQ CHTP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/11/2014Q413($0.07)($0.07)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.05)($0.06)ViewN/AView Earnings Details
3/7/2013Q4 2012($0.08)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Chelsea Therapeutics International (NASDAQ:CHTP)
Current Year EPS Consensus Estimate: $-0.46 EPS
Next Year EPS Consensus Estimate: $-0.31 EPS

Dividends

Dividend History for Chelsea Therapeutics International (NASDAQ:CHTP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Chelsea Therapeutics International (NASDAQ:CHTP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Chelsea Therapeutics International (NASDAQ:CHTP)
Latest Headlines for Chelsea Therapeutics International (NASDAQ:CHTP)
Source:

Social

Chart

Chelsea Therapeutics International (CHTP) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff